{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:29:49Z","timestamp":1791473389939,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.neurobiolaging.2024.11.002","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T08:24:21Z","timestamp":1731572661000},"page":"15-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cross-sectional and longitudinal relationships among blood-brain barrier disruption, Alzheimer's disease biomarkers, and cognition in cognitively normal older adults"],"prefix":"10.1016","volume":"146","author":[{"given":"Marisa","family":"Denkinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa M.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Chadwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Jagust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib1","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49132","article-title":"Cortical tau deposition follows patterns of entorhinal functional connectivity in aging","volume":"8","author":"Adams","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.dib.2017.10.024","article-title":"Considerations and code for partial volume correcting [ 18 F]-AV-1451 tau PET data","volume":"15","author":"Baker","year":"2017","journal-title":"Data Brief."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s44161-021-00014-4","article-title":"Blood\u2013brain barrier link to human cognitive impairment and Alzheimer\u2019s disease","volume":"1","author":"Barisano","year":"2022","journal-title":"Nat. Cardiovasc Res"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12880-015-0062-3","article-title":"ROCKETSHIP: a flexible and modular software tool for the planning, processing and analysis of dynamic MRI studies","volume":"15","author":"Barnes","year":"2015","journal-title":"BMC Med Imaging"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40478-015-0186-2","article-title":"Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy","volume":"3","author":"Blair","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101462","article-title":"Modeling sporadic Alzheimer\u2019s disease in human brain organoids under serum exposure","volume":"8","author":"Chen","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib9","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/jcbfm.2014.126","article-title":"Accurate determination of blood\u2013brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients","volume":"34","author":"Cramer","year":"2014","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1148\/radiol.2016152244","article-title":"Blood-brain barrier leakage in patients with early Alzheimer disease","volume":"281","author":"van de Haar","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0299764","article-title":"Associations between regional blood-brain barrier permeability, aging, and Alzheimer\u2019s disease biomarkers in cognitively normal older adults","volume":"19","author":"Denkinger","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s43587-022-00353-2","article-title":"An empirical measure of resilience explains individual differences in the effect of tau pathology on memory change in aging","volume":"3","author":"Dobyns","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib13","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3390\/cells9092135","article-title":"Mitochondrial calcium deregulation in the mechanism of beta-amyloid and tau pathology","volume":"9","author":"Esteras","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.25406","article-title":"Longitudinal tau accumulation and atrophy in aging and alzheimer disease","volume":"85","author":"Harrison","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib16","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/alz.12249","article-title":"Distinct effects of beta-amyloid and tau on cortical thickness in cognitively healthy older adults","volume":"17","author":"Harrison","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.neuroimage.2015.10.018","article-title":"Tracer kinetic modelling for DCE-MRI quantification of subtle blood\u2013brain barrier permeability","volume":"125","author":"Heye","year":"2016","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib18","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The Pathobiology of Vascular Dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib19","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1212\/WNL.55.4.484","article-title":"Rates of hippocampal atrophy correlate with change in clinical status in aging and AD","volume":"55","author":"Jack","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib21","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S1474-4422(14)70194-2","article-title":"Age-specific population frequencies of cerebral \u03b2-amyloidosis and neurodegeneration among people with normal cognitive function aged 50\u201389 years: a cross-sectional study","volume":"13","author":"Jack","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","article-title":"Imaging the evolution and pathophysiology of Alzheimer disease","volume":"19","author":"Jagust","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41371-020-0352-2","article-title":"Blood\u2013brain barrier dysfunction: the undervalued frontier of hypertension","volume":"34","author":"Katsi","year":"2020","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib24","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3233\/JAD-2009-1197","article-title":"Human Truncated Tau is Using a Different Mechanism from Amyloid-\u03b2 to Damage the Blood-Brain Barrier","volume":"18","author":"Kovac","year":"2009","journal-title":"JAD"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib25","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.neuroimage.2017.05.049","article-title":"The association between tau PET and retrospective cortical thinning in clinically normal elderly","volume":"157","author":"LaPoint","year":"2017","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neurobiolaging.2024.04.003","article-title":"Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders","volume":"140","author":"Libri","year":"2024","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib27","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","article-title":"Distribution volume ratios without blood sampling from graphical analysis of PET data","volume":"16","author":"Logan","year":"1996","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","article-title":"Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer\u2019s disease","volume":"157","author":"Maass","year":"2017","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib29","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1523\/JNEUROSCI.3769-16.2017","article-title":"Tau and \u03b2-amyloid are associated with medial temporal lobe structure, function, and memory encoding in normal aging","volume":"37","author":"Marks","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00401-016-1570-0","article-title":"Brain imaging of neurovascular dysfunction in Alzheimer\u2019s disease","volume":"131","author":"Montagne","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib32","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1084\/jem.20171406","article-title":"Alzheimer\u2019s disease: A matter of blood\u2013brain barrier dysfunction?","volume":"214","author":"Montagne","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood\u2013brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib34","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1177\/0271678X20952012","article-title":"Hippocampal blood\u2013brain barrier permeability is related to the APOE4 mutation status of elderly individuals without dementia","volume":"41","author":"Moon","year":"2021","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib35","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.neuroimage.2011.07.098","article-title":"Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant","volume":"59","author":"Mormino","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib36","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood\u2013brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat. Med"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neurobiolaging.2019.07.005","article-title":"Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adults","volume":"82","author":"Nosheny","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib38","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","article-title":"Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline","volume":"28","author":"Ossenkoppele","year":"2022","journal-title":"Nat. Med"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.1983.1","article-title":"Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data","volume":"3","author":"Patlak","year":"1983","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib40","first-page":"126","article-title":"BACE1 inhibitors block new A\u03b2 plaque formation","volume":"14","author":"Ridler","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bandc.2020.105680","article-title":"Relationship between brain AD biomarkers and episodic memory performance in healthy aging","volume":"148","author":"Rizzolo","year":"2021","journal-title":"Brain Cogn."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib42","first-page":"904","article-title":"Correction for partial volume effects in PET: principle and validation","volume":"39","author":"Rousset","year":"1997","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib43","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011452","article-title":"Neurovascular dysfunction and faulty amyloid -peptide clearance in Alzheimer disease","volume":"2","author":"Sagare","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib44","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of tau deposition in the aging human brain","volume":"89","author":"Sch\u00f6ll","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib45","article-title":"Blood-brain barrier dysfunction in aging induces hyperactivation of TGFb signaling and chronic yet reversible neural dysfunction","volume":"15","author":"Senatorov Jr","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib46","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pscychresns.2008.04.003","article-title":"Blood\u2013brain barrier permeability in Alzheimer\u2019s disease: a case\u2013control MRI study","volume":"171","author":"Starr","year":"2009","journal-title":"Psychiatry Res.: Neuroimaging"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib47","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s43587-022-00204-0","article-title":"Biomarker modeling of Alzheimer\u2019s disease using PET-based Braak staging","volume":"2","author":"Therriault","year":"2022","journal-title":"Nat. Aging"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib48","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jalz.2019.01.013","article-title":"Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations","volume":"15","author":"Thrippleton","year":"2019","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib49","first-page":"463","article-title":"Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model","volume":"10","author":"Ujiie","year":"2003","journal-title":"Microcirculation"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib50","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s11357-020-00211-2","article-title":"Increase in blood\u2013brain barrier leakage in healthy, older adults","volume":"42","author":"Verheggen","year":"2020","journal-title":"GeroScience"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib51","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/brain\/awv112","article-title":"Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation","volume":"138","author":"Villeneuve","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuropharm.2017.12.026","article-title":"Targeted inhibition of RAGE reduces amyloid-\u03b2 influx across the blood-brain barrier and improves cognitive deficits in db\/db mice","volume":"131","author":"Wang","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurobiolaging.2024.11.002_bib53","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458024001866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458024001866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T08:08:37Z","timestamp":1733990917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458024001866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":53,"alternative-id":["S0197458024001866"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2024.11.002","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-sectional and longitudinal relationships among blood-brain barrier disruption, Alzheimer's disease biomarkers, and cognition in cognitively normal older adults","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2024.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}